International Clinical Trials |
 |
|
|
|
|
 |
| |
|
|
|
|
PCI Pharma Services’ Game-Changing Digital Platform
To manage clinical trials from start to finish, you need real-time visibility throughout your clinical and commercial supply chain. Introducing pci | bridge, a transformational platform to ease your clinical trialling processes.
|
|
|
|
|
|
The Colours of Change
Chris Wells at Illingworth Research Group
COVID-19 has been wreaking unrest across the globe, but it is hoped that when the storm passes, that disruption may give way to positive innovation.
|
|
|
|
Engaging the Crowds
Peter Schueler at ICON plc
Patient registries should be attractive to potential patients, but engagement, support, and advocacy are lacking from these networks. Could this be causing a failure to adhere during clinical trials?
|
|
|
|
Direct-to-Patient Trials – Improving Patient Engagement
Sarah Halmrast at CSM
Patient-centricity has become the essential element of any trial, as the pandemic has changed a lot of the ways research was conducted.
|
|
|
|
Clinical Trial Innovation: More Important Now Than Ever
Elizabeth Gargill at BBK Worldwide
Healthcare consumers are desperate for more convenient and cost-effective solutions to trialling that both embrace them as individuals and create a positive experience for them.
|
|
|
|
|
|
The Clinical Development Plan – The Importance of Getting it Right
Barry Drees and Julia Forjanic Klapproth at Trilogy Writing & Consulting
A CDP can ensure that your trial goes smoothly, aiding future research, subsequent trial phases, and speeding up regulatory processes.
|
|
|
|
Accelerating Processes and Enhancing Compliance with Pharmacovigilance Automation
Dr John Price at Arriello
Enhancing pharmacovigilance data is an element of trial innovation that many do not consider. The underappreciated function can benefit many aspects of trials if properly prioritised.
|
|
|
|
Can You Still Work With Empathy When You Work From Home?
Ross Downes at NIHR
While technology and innovation have been an essential aspect of life under lockdown, has our screen-centric existance deprived us of key communication elements?
|
|
|
|
COVID-19 Exposes Untapped Potential in the EU’s Clinical Trial Industry
Angela La Ronde at Greenphire
Sponsors have had to step up to remote trialling during the pandemic, and with this shift came hope that the changes will last, and our technological forward-thinking will continue.
|
|
|
|
Modernisation Movement
Anna Argyris at Veeva Systems
In an interview with Anna Argyris, EPC questions how modernising site operations will change the future landscape of clinical trials, and reduce the burden for patients.
|
|
|
|
|
Using Technology to Streamline Clinical Data Management
Jeff Rogers at Crucial Data Solutions
Trials are taking longer to execute, and teams are being overwhelmed by data. Centralising data and embracing technology can ease the burden on study teams, leaving them more time to focus on their research.
|
|
|
Taking a Fresh Look at CTMSs as an Integral Part of Managing Clinical Trials
Daljit Cheema at PHARMASEAL
Technology has been forced to evolve rapidly during this pandemic, but there is still work to be done. CTMSs are still due for an overhaul and a cloud-based solution may offer a more agile and integrated platform.
|
|
|
Beyond the Data-Hungry Beast
Sheila Rocchio at eClinical Solutions
‘Speed’ is the word on everyone’s lips when it comes to data – faster, smarter, more agile – but these demands are dependent on the adoption of cloud-based CTMS, a process that has been expedited by the pandemic.
|
|
|
|
|
Improving Clinical Trial Outcomes Using AI and Automation
Nagaraja Srivatsan at IQVIA
Saving time in trials shouldn’t come at the cost of patients. By incorporating digital technologies, sponsors can focus on patient experience.
|
|
|
|
A Smart Approach to AI
Vesna Prchkovska and Paulo Rodrigues at QMENTA
Researchers would rather spend their time discovering insights, letting powerful software solutions manage the medical imaging workflow and manipulating and administrating data.
|
|
|
|
The Progress of Real-World Data and Artificial Intelligence
Rob DiCicco at IBM Watson Health
Drug development requires collaboration to reach its full potential. By adopting AI, data don’t have to be an obstacle to this.
|
|
|
|
Streamlining Data Management in Clinical Trials
Jennifer Bradford at PHASTAR
In order to maintain quality, clinical teams can spend hundreds of hours cleaning and managing data when this time is better spent in research.
|
|
|
|
Swimming in Data
Kristin Mauri and Rhonda Roberts at Remarque Systems
The intelligent insights from AI help craft stories from data, aiding every aspect of clinical trials, from enrolment to reporting, so why aren’t these tools being utilised?
|
|
|
|
|
The Psychedelic Renaissance: Psilocybin Study Design Challenges
Charles Raison at Usona Institute
Psychedelics were once a highly excluded aspect of pharmaceutical research, and despite the effectiveness of treatments, there are still some social challenges to overcome.
|
|
|
|
Remote Measures
Shani McCoy at Berkshire Healthcare Foundation Trust (NHS)
The pandemic has meant that many trials have had to halt their research. However, for some of the more vulnerable members of society, the trials are an essential part of their lives, and have had to carry on with great difficulty.
|
|
|
|
Battling Depression: From Clinical Development Strategies to Patient Perspectives
Dr Thomas Thompson, Miaesha Campbell, Jill Adkins, and Joan Gushue at Medpace
Depression is a serious mental disorder affecting millions of people across the world. However, finding an effective treatment is a challenge with no ‘one size fits all’ solution.
|
|
|
|
Non-Invasive Novel Biomarkers to Predict Alzheimer’s Risk
Simon Samaan at Laboratoire Cerba and Jérôme Sallette at Cerba HealthCare
Alzheimer’s research has been a focus of healthcare companies in recent years. While there remains no cure for the disease, biomarkers could hold the key to unlocking our understanding.
|
|
|
|
|
|
_1.jpg)
